Lb Pharmaceuticals (LBRX) Treasury Shares (2024 - 2026)

Lb Pharmaceuticals has reported Treasury Shares for 3 years, with the latest figure at $92000.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $92000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (changed N/A YoY), and the FY2025 full-year result was $6.6 million, up 94857.14% from the prior year.
• Treasury Shares for Q1 2026 stood at $92000.0, down from $6.6 million in the prior quarter.
• The five-year high for Treasury Shares was $6.6 million in Q4 2025, with the low at $7000.0 in Q4 2024.
• Average Treasury Shares over 3 years is $2.2 million, with a median of $92000.0 recorded in 2026.
• Peak annual rise in Treasury Shares reached 94857.14% in 2025, while the deepest fall reached 94857.14% in 2025.
• Tracing LBRX's Treasury Shares over 3 years: stood at $7000.0 in 2024, then jumped by 94857.14% to $6.6 million in 2025, then tumbled by 98.62% to $92000.0 in 2026.
• The last three Treasury Shares figures came in at $92000.0 (Q1 2026), $6.6 million (Q4 2025), and $7000.0 (Q4 2024), per Business Quant data.

Peer Comparison